Snowball logo
logo
4166

Orient Pharma Co. Ltd.

4166 β€’ TWO
NT$23.95NT$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
463.3511.9889.91,222.81,400.41,400.4
COGS
320.7356.5421.2571.3609.7609.7
Gross Profit
142.7155.3468.7651.6790.7790.7
Operating Expenses & Income
Operating Income
(104.4)(33.73)40.26173.9267.1267.1
Total Operating Expenses
276.2197.1440.91,048.91,133.31,133.3
R&D Expenses
219.7129.399.9103.779.9379.93
Selling General & Admin Expenses
48.3957.6267.36373.9443.7443.7
Earnings from Continuing Operations
Interest Expense
(5.701)(7.374)(13.9)(13.97)(7.909)(7.909)
Interest Income
0.5181.0891.6753.6224.344.34
Income Tax Expense
(7.44)(12.35)0.636---
Net Income
Net Income
(102.7)(28.76)22.29107.4208.4208.4
Supplemental
EBIT
(104.4)(33.73)40.26---
EBITDA
(39.21)35.37175.8---
In millions of TWD, except % and values per 1 share